Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Advaxis Inc (ADXS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0694 +0.0087    +14.33%
15:02:00 - Real-time Data. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US0076243072 
S/N:  007624307
  • Volume: 543,802
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0600 - 0.0695
Advaxis 0.0694 +0.0087 +14.33%
IndustryBiotechnology
SectorHealthcare
Employees

18

Equity Type

ORD

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.

Contact Information

Top Executives

Name Age Since Title
Jedd D. Wolchok - - Member of Scientific Advisory Board
Nancy Freitag - - Member of Scientific Advisory Board
Marc Lecuit - - Member of Scientific Advisory Board
Antoni Ribas 54 - Member of Scientific Advisory Board
Robert G. Petit 61 2010 Chairman of Scientific Advisory Board
James P. Patton 63 2002 Independent Vice Chairman of the Board
Roni A. Appel 54 2004 Independent Director
David Sidransky 61 2013 Independent Chairman
Samir N. Khleif 57 2014 Independent Director
Richard Jay Berman 78 2005 Independent Director
Kenneth A. Berlin 58 2018 President, CEO & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ADXS Comments

Write your thoughts about Advaxis Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Name Last Name
Name Last Name Oct 19, 2021 4:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks like they have to resplit atleast 10:1 and than plummet again
Joe Velasquez
Joe Velasquez Sep 20, 2021 9:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy ONE it's gonna explode
Pablo M.
Pablo M. Sep 18, 2021 3:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://invst.ly/w2bgu ... Practically ready 👀
dr palchauk
dr palchauk Aug 18, 2021 5:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Biosight's Aspacytarabine will be a huge success. Blockbuster drug. Mark my word.
The Quiter
The Quiter Aug 18, 2021 5:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When this will be approved
Ceyhun Çetinkaya
Ceyhun Çetinkaya Jul 26, 2021 3:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whats going on this stock?premarket $6??
Rami Shamali
Rami Shamali Jul 26, 2021 3:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
something is wrong about the website :)
adrian florin
adrian florin Jul 26, 2021 3:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
maybe reverse split?
Neteli Neteli
Neteli Neteli Jul 26, 2021 3:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hha i wish it was real...but something is wrong with the website as this is not the only stock showing wrong market price.
esam awwad
esam awwad Jul 15, 2021 6:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
today must be green and up to 0.75 at least
esam awwad
esam awwad Jul 07, 2021 11:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
just wait it will be better nearly it's super merge
esam awwad
esam awwad Jul 07, 2021 12:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target price today guys???
Chris Laflame
Chris Laflame Jul 07, 2021 12:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
4 me : 0.44 would be great
esam awwad
esam awwad Jul 06, 2021 11:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
to the moon 🌙🌙🌙🌙
Neteli Neteli
Neteli Neteli Jul 06, 2021 7:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Advaxis and Biosight Announce Entry into Definitive Merger Agreement
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email